Secondary Intention Healing After Mohs Micrographic Surgery: An Updated Review of Classic and Novel Applications, Benefits and Complications
Actas Dermo-Sifiliográficas · 2025-05 · 116 (5) · 511-520
DOI: 10.1016/j.ad.2024.09.024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Actas Dermo-Sifiliográficas, 2025-05. Verfasst von J Gil-Lianes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Spain. Hauptthemen laut MEDLINE: Mohs Surgery, Wound Healing, Skin Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Spain.
- Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Spain. Electronic address: morgadodaniel8@gmail.com.
Zitieren
APA
Gil-Lianes, J., Marti-Marti, I., & Morgado-Carrasco, D. (2025). Secondary Intention Healing After Mohs Micrographic Surgery: An Updated Review of Classic and Novel Applications, Benefits and Complications. Actas Dermo-Sifiliográficas, 116(5), 511-520. https://doi.org/10.1016/j.ad.2024.09.024
Vancouver
Gil-Lianes J, Marti-Marti I, Morgado-Carrasco D. Secondary Intention Healing After Mohs Micrographic Surgery: An Updated Review of Classic and Novel Applications, Benefits and Complications. Actas Dermo-Sifiliográficas. 2025;116(5):511-520. doi:10.1016/j.ad.2024.09.024
BibTeX
@article{GilLianes2025,
author = {Gil-Lianes, J and Marti-Marti, I and Morgado-Carrasco, D},
title = {Secondary Intention Healing After Mohs Micrographic Surgery: An Updated Review of Classic and Novel Applications, Benefits and Complications},
journal = {Actas Dermo-Sifiliográficas},
year = {2025},
volume = {116},
number = {5},
pages = {511--520},
doi = {10.1016/j.ad.2024.09.024}
}
EUVIMED